Sam Paglinco, DO
@SamPaglinco
Followers
98
Following
196
Statuses
88
IBD advocate, physician and patient • Peds GI 💩• sloth lover 🦥• trying to make the world a better place 🌎• tweets are my own and not medical advice
Joined March 2022
@jsmkhoo @RossMaltz I would be careful what you wish for @jsmkhoo you may end up with a new project or @RossMaltz will tell you to write your current manuscripts 🤣
0
0
0
It has been an amazing 3 years @RossMaltz. I can’t believe it is an end of an era. You have taught me so much and I still have so much to learn from you. I will make a list of things you still have to teach me for our next research meeting.
So sad to see my mentee, GI fellow, researcher, and friend @SamPaglinco graduate and move on to great things. I know we will keep in touch especially since we have a research meeting on July 2nd. Picture from a card she gave me. A picture of us holding her research award.
0
0
1
RT @SCKimIBDMD: Day on the Hill with colleagues from @naspghan: we discussed legislation (#MNEA & #StepTherapy) critical to patient care an…
0
3
0
RT @csbonta: State and federal lawmakers need to stop insurance companies and PBMs from practicing medicine without a license. Make no mist…
0
2
0
RT @BernieSanders: This week Cigna said it would be spending $11.3 billion not to lower premiums, deductibles, or improve health care for i…
0
1K
0
RT @mcuban: Everyone doubted us. Said we couldn't impact an industry that no one trusts. Here we are less than 2 years later announcing we…
0
798
0
RT @PLLU: Just part of the @nationwidekids GI team at our @OhioStateFB tailgate yesterday. 10-0 and not done yet. Go Bucks! @MGrishamMD @R…
0
4
0
RT @DCharabaty: This editorial is🌟in many ways 🫶🏾Partnering w @ReezwanaCMD who was my GI fellow & now an IBD colleague💜 🔎@tinahamd & al.…
0
18
0
Losses of exclusivity for biologics and intro of biosimilars have increased in the past three years, with brand sales of those products dropping by $33Bn over the past five years compared to $4Bn over the prior five years and reflecting a growing role for biosimilars.
0
3
5
RT @jsmkhoo: 🦥🦥🦥 are going to have a hard time escaping! We really need to find a good hiding place!! @SamPaglinco @MGrishamMD
@NCHforFel…
0
1
0
It is really hard to do proactive TDM with adalimumab. (Since it requires an extra trip to the lab right before an injection). This is an important consideration when doing shared decision with families on initiating infliximab or adalimumab. @andrewbgrossman #ICNCCF23
0
1
8
RT @SCKimIBDMD: “Only” 10 years old yet possessing poise, passion and leadership skills surpassing those far older: Samantha and her wonder…
0
3
0
Wouldn’t have been able to do this without the mentorship and emotional support of @RossMaltz and the very data driven #TwitterlessBoyle
#ICNCCF23
0
0
3
RT @Flat_Jennie: “Stay strong and you’ll do great.” Words of wisdom from a 10 y.o. powerhouse IBDer. ✨ #ICNCCF23 @ImproveCareNow @ICNPati…
0
4
0
RT @Flat_Jennie: Learning about how early, appropriate use of surgery in #IBD is an important tool from @MLongMD, so essential to remember…
0
3
0
Confused 🤷🏻♀️🤷🏻♂️on all of the adalimumab biosimilars and the difference among them?! Me too! I can’t keep the differences straight. Below is an awesome resource for information on adalimumab biosimilars! #ICNCCF23
0
2
2
We have work to do 💪🏼to close the gaps of inequities so ALL children get the care they deserve. Addressing social determinants of health is important. #ICNCCF23
Ongoing call to action for our community to meaningfully and sustainably address inequities in pediatric #IBD for *all* our kids to have accessible, equitable, interdisciplinary, & excellent care @ImproveCareNow @ICNPatients #ICNCCF23
0
2
7
@deslilo @jsmkhoo @CarloDiLorenzo1 @johnbarnardmd @PLLU @Nationwide @RSanchez490MD @RossMaltz @juliavdzande @LauraHamant @NDavidsonMD @MuhammadKhanMD @JenniferLeeLee1 This is another example of your sneakiness @deslilo and why you are #therealdrD
0
0
3